Suture Needle Market Size was valued at USD 3.6 Billion in 2022. The Suture Needle market Shape is projected to grow from USD 3.8 Billion in 2023 to USD 5.8 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.80% during the forecast period (2023 - 2032). Increase in the number of cardiovascular surgery procedures and the incidence of chronic conditions, are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The rise of chronic diseases and an increase in the number of surgeries for cardiovascular conditions are driving the market's expansion. Furthermore, the development of cutting-edge technical solutions will help the market for suture needles. For instance, Healthium Medtech unveiled Truglyde SN2355, a set of suture needles created exclusively for COMOC MG, a novel surgical strategy for treating postpartum haemorrhage (PPH), one of the main causes of maternal death, in May 2020.
The WHO estimates that 2,94,046 deaths worldwide and more than 42,48,389 recorded cases of COVID-19 occurred in May 2020. healthcare delivery has been significantly disrupted by the epidemic, especially efforts to treat chronic ailments like heart disease. Cardiology diagnostic procedures were down 64% overall from the prior year across all geographical areas. On the other hand, 22% of centres reported a lack of high-filtration masks and personal protective equipment (PPE) for medical staff, which restricted their ability to provide care. This supply crunch has had an adverse impact on the suture needle market.
The demand for surgical care is expected to increase due to the increased frequency of cardiovascular diseases worldwide. According to the WHO, 17.9 million deaths ly from cardiovascular diseases—or 32% of all deaths—occurred in 2019. Furthermore, a sizable fraction of these fatalities may be caused by heart attacks and strokes.
The market is expected to increase as a result of numerous initiatives, including product launches, mergers, and acquisitions by significant industry participants. For instance, Ethicon, a division of Johnson & Johnson Medical Devices Companies, introduced The ProxiSure (TM) Suturing Device in August 2017 as a cutting-edge laparoscopic suturing device incorporating Ethicon endomechanical, suture, and curved needle technology. With a very intuitive tissue healing experience, ProxiSure (TM) was created to deliver precision suturing in constrained areas. It is especially well-suited for bariatric, general, colorectal, and gynaecological surgeries. The device's curved needle also enhances a surgeon's ability to suture a variety of tissue layers, including flat surfaces. Consequently, it is anticipated that the market for suture needles will expand as a result of such new developments. Thus, driving the Suture Needle market revenue.
The Suture Needle market segmentation, based on Shape, includes straight shaped needles, j-shape needles, compound curve shaped needles, and half-curved. Straight shaped needles segment dominated the market in 2022. The segment's expansion is related to the rise in popularity of rhinoplasty and abdominal surgery. In microsurgery, it's also applied to promote nerve and vascular repair. The straight-body needle, in contrast to other needle types, is used to suture tissue that is readily accessible and manageable by hand. Over the course of the projected period, the half-curved needle sector is anticipated to have substantial growth. This is due to the predictable path a half-curved needle takes through tissue and the fact that it is smaller than a straight needle.
The Suture Needle market segmentation, based on type, includes eyed needles and eyeless. Eyed needles segment dominated the market in 2022. Suture needle demand is expected to increase due to the eyed needles' ability to puncture easily penetrated tissues (such as the subcutaneous layers, dura, peritoneum, and abdominal viscera) while minimising fascia tearing. Over the course of the projected period, a significant growth rate is anticipated for the blunt point needle segment. Since blunt point needles can be used in place of conventional curved needles and greatly reduce risk exposures during surgical procedures, they are recommended as an alternative to taper point needles and are expected to drive market growth in the near future.
Figure 1 Suture Needle Market, by End User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The Suture Needle market segmentation, based on End User, includes ambulatory surgical centers, hospital, clinics and others. Hospital segment dominated the suture needle market in 2022. This is brought on by an increase in the number of serious diseases that require surgery as well as new developments in imaging, surgical technology, and diagnosis.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Suture Needle Market dominated this market in 2022 (45.80%). This is achievable because cardiovascular illnesses, which currently account for more than one-third of all fatalities in the United States, are quite common and have a quick uptake of minimally invasive therapy. The American Heart Association predicts that by 2030, there will be twice as many old people as there are now, and that cardiovascular diseases will continue to be the leading cause of mortality and morbidity among them. Further, the U.S. Suture Needle market held the largest market share, and the Canada Suture Needle market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 SUTURE NEEDLE MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Suture Needle market accounted for the healthy market share in 2022. This is because to things like a high number of surgeries, a rise in consumer disposable income, and the launch of technologically advanced items as a result of market participants investing in the area. Further, the German Suture Needle market held the largest market share, and the U.K Suture Needle market was the fastest growing market in the European region
The Asia Pacific Suture Needle market is expected to register significant growth from 2023 to 2032. The growth in surgical operations and medical tourism is a key factor driving the market in emerging nations. As a result, market expansion is probably going to pick up speed soon. Moreover, China’s Suture Needle market held the largest market share, and the Indian Suture Needle market was the fastest growing market in the Asia-Pacific region.
Suture Needle Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Suture Needle market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Suture Needle Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Suture Needle Industry to benefit clients and increase the market sector. In recent years, the Suture Needle Industry has offered some of the most significant advantages to medicine. Major players in the Suture Needle market, including Hu-Friedy Mfg. Co., Roboz Surgical Instrument, Hill-Rom, Medline Industries Inc., B. Braun Melsungen AG, Medtronic Plc, and Johnson & Johnson Services Inc., are attempting to increase market demand by investing in research and development operations.
A medical technology firm called Medtronic Plc (Medtronic), originally known as Medtronic Inc., creates, develops, produces, and sells a variety of medical products. It provides products for the treatment of conditions such heart valve issues, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions. Additionally, it offers biologic solutions for the dental and orthopaedic markets. In Asia Pacific, Europe, the Americas, the Middle East, and Africa, it provides its products to hospitals, third-party healthcare providers, clinics, institutions, including governmental health care programmes, distributors, and group purchasing organisations. The headquarters of Medtronic are in Dublin, Ireland. A partnership between Medtronic and Vizient for an Al-powered video management system was announced in March 2022. This will make procedure videos accessible to surgical teams.
The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted technologies, knee and hip implants to replace sick, worn, or damaged joints, trauma-related items to stabilise fractures, and deformity repair operations. Additionally, it provides items for treating wounds as well as tools and materials for removing and repairing soft tissue. Surgeons, nurses, nurse specialists, doctors, general practitioners, buying staff at hospitals, and health insurers are among the groups to which Smith & Nephew makes its goods available. The company sells its goods across Africa, the Middle East, Asia-Pacific, Europe, and North America. The UK's Hertfordshire county of Watford is home to Smith & Nephew's headquarters. Smith and Nephew announced in November 2020 that their recently created Novostitch Meniscal repair technology has a success rate of 82.6% when treating Horizontal Cleavage rips.
Key Companies in the Suture Needle market include
Suture Needle Industry Developments
August 2021:AbGel, a Mumbai-based manufacturer of gelatin sponges, was acquired by Healthium in full, enabling it to increase the scope of its post-surgery and surgical care product offerings. With the addition of hemostats, a urology portfolio, a patented arthroscopy, gloves, surgical sutures, needles, hernia meshes and surgical staplers, their product line has been strengthened.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 3.6 Billion |
| Market Size 2023 | USD 3.8 Billion |
| Market Size 2032 | USD 5.8 Billion |
| Compound Annual Growth Rate (CAGR) | 18.80% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Shape, Type, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Hu-Friedy Mfg. Co., Roboz Surgical Instrument, Hill-Rom, Medline Industries Inc., B. Braun Melsungen AG, Medtronic Plc, and Johnson & Johnson Services Inc. |
| Key Market Opportunities | Technological advancements and favorable reimbursement scenario |
| Key Market Dynamics | Surge in the number of surgical procedures for cardiovascular diseases and the increasing prevalence of chronic diseases |
Suture Needles Market Highlights:
Frequently Asked Questions (FAQ) :
The Suture Needle market size was valued at USD 3.6 Billion in 2022.
The market is projected to grow at a CAGR of 18.80% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are Hu-Friedy Mfg. Co., Roboz Surgical Instrument, Hill-Rom, Medline Industries Inc., B. Braun Melsungen AG, Medtronic Plc, and Johnson & Johnson Services Inc.
The Straight Shaped Needles Shape dominated the market in 2022.
The Eyed Needles Type had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
